𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liver transplantation for hepatocellular carcinoma: clinical results and future aspects

✍ Scribed by Rudolf Pichlmayr; Arved Weimann; Gustav Steinhoff; Burckhardt Ringe

Publisher
Springer
Year
1992
Tongue
English
Weight
549 KB
Volume
31
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Liver transplantation for hepatocellular
Liver transplantation for hepatocellular carcinoma
✍ Alan P. Venook πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 277 KB πŸ‘ 1 views

Background: Liver transplantation for unresectable hepatocellular carcinoma yields disappointing results. Most cases recur within 2 years, often in the transplanted liver. Methods: A combination of neoadjuvant doxorubicin and orthotopic liver transplantation was used in 20 patients with unresectable

Liver transplantation for hepatocellular
Liver transplantation for hepatocellular carcinoma: Results with preoperative chemoembolization
✍ Venook, Alan P. ;Ferrell, Linda D. ;Roberts, John P. ;Emond, Jean ;Frye, John W. πŸ“‚ Article πŸ“… 1995 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 572 KB

patients who met the following criteria-hepatic tumor unresectable because of location or inadequate liver reserve, no metastases, HBsAg negative, no tumor larger than 5 cm in diameter, and no more than three tumors-were enrolled prospectively in a protocol employing preoperative chemoembolization t

Liver transplantation for non–hepatocell
Liver transplantation for non–hepatocellular carcinoma malignancies
✍ Gregory J. Gores; Julie K. Heimbach; Charles B. Rosen πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 139 KB

## Key Points 1. Hepatic epithelioid hemangioendothelioma is a rare disease with a variable natural history; current data support liver transplantation for unresectable disease. 2. Anti-vascular endothelial cell growth factor therapy may change the approach to hepatic epithelioid hemangioendotheli